Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
11271 Results
10661
Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder
Type: Journal Article
Authors: Natalia Shcherbakova, Gary Tereso, Jacqueline Spain, Robert J. Roose
Year: 2018
Publication Place: United States
Abstract:

BACKGROUND: Persistence with medication-assisted therapy among patients with opioid use disorder has been associated with reduced likelihood of illicit opioid use. OBJECTIVE: We aimed to describe treatment persistence and identify factors associated with 1-year persistence among insured patients newly initiating buprenorphine-containing pharmacotherapy. METHODS: The retrospective observational cohort included employer-sponsored and managed Medicaid patients newly started on buprenorphine-containing therapy between June 30, 2010, and January 1, 2015. Persistence was measured as both a continuous and dichotomous variable (proportion of patients persistent for 1 year). Multivariable logistic regression analysis was used to identify factors associated with 1-year persistence. RESULTS: A total of 302 patients met inclusion criteria. The median [range] number of treatment episodes was 1 [1-4]. Mean number of days on therapy during the first episode was 206 (SD = 152) days, with 40.4% (n = 122) of patients persisting for 1 year. Presence of concomitant fills of prescription opioid analgesics (odds ratio [OR] = 0.25; 95% CI = 0.12-0.51), being in care of an addiction specialist (OR = 0.40; 95% CI = 0.21-0.76), and Medicaid insurance coverage (OR = 0.33; 95% CI = 0.13-0.84) were significantly and negatively associated with 1-year persistence. There was also a strong inverse relationship between persistence and inpatient hospitalization (OR = 0.30; 95% CI = 0.12-0.76). CONCLUSIONS: Several health care delivery and use variables were significantly associated with nonpersistence. Concomitant use of prescription opioids is the most easily modifiable risk factor that health care providers and policy makers may act on to improve treatment continuation.

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
10662
Treatment preference for opioid use disorder among people who are incarcerated
Type: Journal Article
Authors: Eliana Kaplowitz, Ashley Q. Truong, Justin Berk, Rosemarie A. Martin, Jennifer G. Clarke, Morgan Wieck, Josiah Rich, Lauren Brinkley-Rubenstein
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
10664
Treatment research in prison: Problems and solutions in a randomized trial
Type: Journal Article
Authors: Philipp Paul Lobmaier, Nikolaj Kunoe, Helge Waal
Year: 2010
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
10665
Treatment resistant depression in primary care: Co-constructing difficult encounters
Type: Journal Article
Authors: Susan McPherson, Richard Byng, Donna Oxley
Year: 2014
Topic(s):
General Literature See topic collection
10666
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Type: Journal Article
Authors: Y. I. Hser, A. J. Saxon, D. Huang, A. Hasson, C. Thomas, M. Hillhouse, P. Jacobs, C. Teruya, P. McLaughlin, K. Wiest, A. Cohen, W. Ling
Year: 2014
Publication Place: England
Topic(s):
Opioids & Substance Use See topic collection
10667
Treatment Retention in Opioid Dependent Clients Receiving Medication-Assisted Treatment: Six-Month Rate and Baseline Correlates
Type: Journal Article
Authors: Michael Fendrich, Jessica Becker, Melissa Ives, Eleni Rodis, Martha Marín
Year: 2021
Publication Place: Philadelphia, Pennsylvania
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
10669
Treatment selection and treatment initialization in guideline-based stepped and collaborative care for depression
Type: Journal Article
Authors: D. Heddaeus, M. Steinmann, A. Daubmann, M. Harter, B. Watzke
Year: 2018
Publication Place: United States
Abstract: In order to optimize patient allocation, guidelines recommend stepped and collaborative care models (SCM) including low-intensity treatments. The aim of this study is to investigate the implementation of guideline-adherent treatments in a SCM for depression in routine care. We analyzed care provider documentation data of n = 569 patients treated within a SCM. Rates of guideline-adherent treatment selections and initializations as well as accordance between selected and initialized treatment were evaluated for patients with mild, moderate and severe depression. Guideline-adherent treatment selection and initialization was highest for mild depression (91% resp. 85%). For moderate depression, guideline-adherent treatments were selected in 68% and applied in 54% of cases. Guideline adherence was lowest for severe depression (59% resp. 19%). In a multiple mixed logistic regression model a significant interaction between guideline adherence in treatment selection/initialization and severity degree was found. The differences between treatment selection and initialization were significant for moderate (OR: 1.8 [95% CI: 1.30 to 2.59; p = 0.0006]) and severe depression (OR: 6.9; [95% CI: 4.24 to 11.25; p < .0001] but not for mild depression (OR = 1.8, [95%-CI: 0.68 to 4.56; p = 0.2426]). Accordance between selected and initialized treatment was highest for mild and lowest for severe depression. We conclude that SCMs potentially improve care for mild depression and guideline adherence of treatment selections. Guideline adherence of treatment initialization and accordance between treatment selection and initialization varies with depression severity. Deficits in treating severe depression adequately may be more a problem of failed treatment initializations than of inadequate treatment selections.
Topic(s):
General Literature See topic collection
10670
Treatment selection and treatment initialization in guideline-based stepped and collaborative care for depression
Type: Journal Article
Authors: D. Heddaeus, M. Steinmann, A. Daubmann, M. Harter, B. Watzke
Year: 2018
Publication Place: United States
Abstract: In order to optimize patient allocation, guidelines recommend stepped and collaborative care models (SCM) including low-intensity treatments. The aim of this study is to investigate the implementation of guideline-adherent treatments in a SCM for depression in routine care. We analyzed care provider documentation data of n = 569 patients treated within a SCM. Rates of guideline-adherent treatment selections and initializations as well as accordance between selected and initialized treatment were evaluated for patients with mild, moderate and severe depression. Guideline-adherent treatment selection and initialization was highest for mild depression (91% resp. 85%). For moderate depression, guideline-adherent treatments were selected in 68% and applied in 54% of cases. Guideline adherence was lowest for severe depression (59% resp. 19%). In a multiple mixed logistic regression model a significant interaction between guideline adherence in treatment selection/initialization and severity degree was found. The differences between treatment selection and initialization were significant for moderate (OR: 1.8 [95% CI: 1.30 to 2.59; p = 0.0006]) and severe depression (OR: 6.9; [95% CI: 4.24 to 11.25; p < .0001] but not for mild depression (OR = 1.8, [95%-CI: 0.68 to 4.56; p = 0.2426]). Accordance between selected and initialized treatment was highest for mild and lowest for severe depression. We conclude that SCMs potentially improve care for mild depression and guideline adherence of treatment selections. Guideline adherence of treatment initialization and accordance between treatment selection and initialization varies with depression severity. Deficits in treating severe depression adequately may be more a problem of failed treatment initializations than of inadequate treatment selections.
Topic(s):
General Literature See topic collection
10671
Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
Type: Journal Article
Authors: K . Y. Xu, A. K. Gertner, S. F. Greenfield, A. R. Williams, R. A. Grucza
Year: 2024
Topic(s):
Opioids & Substance Use See topic collection
,
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
10672
Treatment trajectories and barriers in opioid agonist therapy for people who inject drugs in rural Puerto Rico
Type: Journal Article
Authors: Roberto Abadie, Katherine McLean, Patrick Habecker, Kirk Dombrowski
Year: 2021
Publication Place: Elmsford
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
10673
Treatment Use and Costs Among Privately Insured Youths With Diagnoses of Bipolar Disorder
Type: Journal Article
Authors: S. B. Dusetzina, J. F. Farley, M. Weinberger, B. N. Gaynes, B. Sleath, R. A. Hansen
Year: 2012
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
10674
Treatment utilization among persons with opioid use disorder in the United States
Type: Journal Article
Authors: Li-Tzy Wu, He Zhu, Marvin S. Swartz
Year: 2016
Topic(s):
Opioids & Substance Use See topic collection
10675
Treatment utilization among persons with opioid use disorder in the United States
Type: Journal Article
Authors: Li-Tzy Wu, He Zhu, Marvin S. Swartz
Year: 2016
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
10676
Treatments for opioid use disorder among pregnant and reproductive-aged women
Type: Journal Article
Authors: D. J. Hand, V. L. Short, D. J. Abatemarco
Year: 2017
Publication Place: United States
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
10677
Treatments for Substance Use Disorders
Type: Web Resource
Authors: Substance Abuse and Mental Health Administration
Year: 2016
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

10678
Tree analysis modeling of the associations between phq-9 depressive symptoms and doctor diagnosis of depression in primary care
Type: Journal Article
Authors: Weng-Yee Chin, Eric Yuk Fai Wan, Christopher Dowrick, Bruce Arroll, Cindy Lo Kuen Lam
Year: 2018
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
10679
Trending the evidence on opioid use disorder (OUD) continuum of care among rural American Indian/Alaskan Native (AI/AN) tribes: A systematic scoping review
Type: Journal Article
Authors: Elias Mpofu, Stanley Ingman, Patricia Matthews-Juarez, Solymar Rivera-Torres, Paul D. Juarez
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
10680
Trends and Disparities in Perinatal Opioid Use Disorder Treatment in Medicaid, 2007-2012
Type: Journal Article
Authors: R. K. Landis, B. D. Stein, A. W. Dick, B. A. Griffin, B. K. Saloner, M. Terplan, L. J. Faherty
Year: 2024
Abstract:

We described Medicaid-insured women by receipt of perinatal opioid use disorder (OUD) treatment; and trends and disparities in treatment. Using 2007 to 2012 Medicaid Analytic eXtract data from 45 states and D.C., we identified deliveries among women with OUD. Regressions modeled the association between patient characteristics and receipt of any OUD treatment, medication for OUD (MOUD), and counseling alone during the perinatal period. Rates of any OUD treatment and MOUD for women with perinatal OUD increased over the study period, but trends differed by subgroup. Compared with non-Hispanic White women, Black and American Indian/Alaskan Native (AI/AN) women were less likely to receive any OUD treatment, and Black women were less likely to receive MOUD. Over time, the disparity in receipt of MOUD between Black and White women increased. Overall gains in OUD treatment were driven by improvements in perinatal OUD care for White women and obscured disparities for Black and AI/AN women.

Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Financing & Sustainability See topic collection